ARMISTICE CAPITAL LLC 13D and 13G filings for Vincerx Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:13 pm Sale | 2025-03-31 | 13G | Vincerx Pharma, Inc. VINC | ARMISTICE CAPITAL LLC | 274,908 4.990% | -4,200,213 (-93.86%) | Filing |
| 2025-02-14 5:22 pm Purchase | 2024-12-31 | 13G | Vincerx Pharma, Inc. VINC | ARMISTICE CAPITAL LLC | 4,475,121 9.990% | 4,475,121 (New Position) | Filing |